Lifestyle and sociodemographic factors associated with high-risk HPV infection in UK women

Seonaidh Claire Cotton (Corresponding Author), Linda Sharp, R. Seth, Lindsey Fiona Masson, Julian Little, Margaret Eleanor Cruickshank, K. Neal, Norman Robert Waugh, The TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) Group

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

The world age-standardised prevalence of high-risk HPV (hrHPV) infection among 5038 UK women aged 20–59 years, with a low-grade smear during 1999–2002, assessed for eligibility for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) was 34.2%. High-risk HPV prevalence decreased with increasing age, from 61% at ages 20–24 years to 14–15% in those over 50 years. The age-standardised prevalence was 15.1, 30.7 and 52.7%, respectively, in women with a current normal, borderline nuclear abnormalities (BNA) and mild smear. In overall multivariate analyses, tertiary education, previous pregnancy and childbirth were associated with reduced hrHPV infection risk. Risk of infection was increased in non-white women, women not married/cohabiting, hormonal contraceptives users and current smokers. In stratified analyses, current smear status and age remained associated with hrHPV infection. Data of this type are relevant to the debate on human papillomavirus (HPV) testing in screening and development of HPV vaccination programmes.
Original languageEnglish
Pages (from-to)133-139
Number of pages7
JournalBritish Journal of Cancer
Volume97
Issue number1
DOIs
Publication statusPublished - 2007

Fingerprint

Life Style
Infection
Contraceptive Agents
Vaccination
Multivariate Analysis
Parturition
Education
Pregnancy

Keywords

  • HPV infection
  • lifestyle factors
  • cervical cancer
  • human-papillomavirus infection
  • cervical intraepithelial neoplasia
  • young-women
  • sexual-behavior
  • contraceptive use
  • prevalence surveys
  • particle vaccine
  • natural-history
  • pooled analysis
  • health-risk

Cite this

Cotton, S. C., Sharp, L., Seth, R., Masson, L. F., Little, J., Cruickshank, M. E., ... The TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) Group (2007). Lifestyle and sociodemographic factors associated with high-risk HPV infection in UK women. British Journal of Cancer, 97(1), 133-139. https://doi.org/10.1038/sj.bjc.6603822

Lifestyle and sociodemographic factors associated with high-risk HPV infection in UK women. / Cotton, Seonaidh Claire (Corresponding Author); Sharp, Linda; Seth, R.; Masson, Lindsey Fiona; Little, Julian; Cruickshank, Margaret Eleanor; Neal, K.; Waugh, Norman Robert; The TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) Group.

In: British Journal of Cancer, Vol. 97, No. 1, 2007, p. 133-139.

Research output: Contribution to journalArticle

Cotton, SC, Sharp, L, Seth, R, Masson, LF, Little, J, Cruickshank, ME, Neal, K, Waugh, NR & The TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) Group 2007, 'Lifestyle and sociodemographic factors associated with high-risk HPV infection in UK women', British Journal of Cancer, vol. 97, no. 1, pp. 133-139. https://doi.org/10.1038/sj.bjc.6603822
Cotton, Seonaidh Claire ; Sharp, Linda ; Seth, R. ; Masson, Lindsey Fiona ; Little, Julian ; Cruickshank, Margaret Eleanor ; Neal, K. ; Waugh, Norman Robert ; The TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) Group. / Lifestyle and sociodemographic factors associated with high-risk HPV infection in UK women. In: British Journal of Cancer. 2007 ; Vol. 97, No. 1. pp. 133-139.
@article{6bd7b75bf7564e70b4be401b90f2fb64,
title = "Lifestyle and sociodemographic factors associated with high-risk HPV infection in UK women",
abstract = "The world age-standardised prevalence of high-risk HPV (hrHPV) infection among 5038 UK women aged 20–59 years, with a low-grade smear during 1999–2002, assessed for eligibility for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) was 34.2{\%}. High-risk HPV prevalence decreased with increasing age, from 61{\%} at ages 20–24 years to 14–15{\%} in those over 50 years. The age-standardised prevalence was 15.1, 30.7 and 52.7{\%}, respectively, in women with a current normal, borderline nuclear abnormalities (BNA) and mild smear. In overall multivariate analyses, tertiary education, previous pregnancy and childbirth were associated with reduced hrHPV infection risk. Risk of infection was increased in non-white women, women not married/cohabiting, hormonal contraceptives users and current smokers. In stratified analyses, current smear status and age remained associated with hrHPV infection. Data of this type are relevant to the debate on human papillomavirus (HPV) testing in screening and development of HPV vaccination programmes.",
keywords = "HPV infection, lifestyle factors, cervical cancer, human-papillomavirus infection, cervical intraepithelial neoplasia, young-women, sexual-behavior, contraceptive use, prevalence surveys, particle vaccine, natural-history, pooled analysis, health-risk",
author = "Cotton, {Seonaidh Claire} and Linda Sharp and R. Seth and Masson, {Lindsey Fiona} and Julian Little and Cruickshank, {Margaret Eleanor} and K. Neal and Waugh, {Norman Robert} and {The TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) Group}",
year = "2007",
doi = "10.1038/sj.bjc.6603822",
language = "English",
volume = "97",
pages = "133--139",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Lifestyle and sociodemographic factors associated with high-risk HPV infection in UK women

AU - Cotton, Seonaidh Claire

AU - Sharp, Linda

AU - Seth, R.

AU - Masson, Lindsey Fiona

AU - Little, Julian

AU - Cruickshank, Margaret Eleanor

AU - Neal, K.

AU - Waugh, Norman Robert

AU - The TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) Group

PY - 2007

Y1 - 2007

N2 - The world age-standardised prevalence of high-risk HPV (hrHPV) infection among 5038 UK women aged 20–59 years, with a low-grade smear during 1999–2002, assessed for eligibility for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) was 34.2%. High-risk HPV prevalence decreased with increasing age, from 61% at ages 20–24 years to 14–15% in those over 50 years. The age-standardised prevalence was 15.1, 30.7 and 52.7%, respectively, in women with a current normal, borderline nuclear abnormalities (BNA) and mild smear. In overall multivariate analyses, tertiary education, previous pregnancy and childbirth were associated with reduced hrHPV infection risk. Risk of infection was increased in non-white women, women not married/cohabiting, hormonal contraceptives users and current smokers. In stratified analyses, current smear status and age remained associated with hrHPV infection. Data of this type are relevant to the debate on human papillomavirus (HPV) testing in screening and development of HPV vaccination programmes.

AB - The world age-standardised prevalence of high-risk HPV (hrHPV) infection among 5038 UK women aged 20–59 years, with a low-grade smear during 1999–2002, assessed for eligibility for TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) was 34.2%. High-risk HPV prevalence decreased with increasing age, from 61% at ages 20–24 years to 14–15% in those over 50 years. The age-standardised prevalence was 15.1, 30.7 and 52.7%, respectively, in women with a current normal, borderline nuclear abnormalities (BNA) and mild smear. In overall multivariate analyses, tertiary education, previous pregnancy and childbirth were associated with reduced hrHPV infection risk. Risk of infection was increased in non-white women, women not married/cohabiting, hormonal contraceptives users and current smokers. In stratified analyses, current smear status and age remained associated with hrHPV infection. Data of this type are relevant to the debate on human papillomavirus (HPV) testing in screening and development of HPV vaccination programmes.

KW - HPV infection

KW - lifestyle factors

KW - cervical cancer

KW - human-papillomavirus infection

KW - cervical intraepithelial neoplasia

KW - young-women

KW - sexual-behavior

KW - contraceptive use

KW - prevalence surveys

KW - particle vaccine

KW - natural-history

KW - pooled analysis

KW - health-risk

U2 - 10.1038/sj.bjc.6603822

DO - 10.1038/sj.bjc.6603822

M3 - Article

VL - 97

SP - 133

EP - 139

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 1

ER -